Multicenter evaluation of analytical characteristics of the Elecsys^® Periostin immunoassay

详细信息    查看全文

• 作者：Stefan Palme^a ; ^{Stefan.palme@roche.com} ; Robert H. Christenson^b ; ^{rchristenson@umm.edu} ; Saeed A. Jortani^c ; ^{saeed.jortani@louisville.edu} ; Richard E. Ostlund^d ; ^{rostlund@wustl.edu} ; Ruediger Kolm^a ; ^{ruediger.kolm@roche.com} ; Guido Kopal^a ; ^{guido.kopal@roche.com} ; Ruediger P. Laubender^a ; ^e ; ^{ruediger.laubender@roche.com}
• 关键词：CLSI ; Clinical and laboratory standards institute ; CLCS ; Washington University Core Laboratory for Clinical Studies ; ELISA ; enzyme-linked immunosorbent assay ; KCTL ; Kentucky Clinical Trials Laboratory ; LoB ; limit of blank ; LoD ; limit of detection ; LoQ ; limit of quantification ; NAC ; N-acetylcysteine ; UoM ; University of Maryland Clinical Chemistry Research Lab
• 刊名：Clinical Biochemistry
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：50
• 期：3
• 页码：139-144
• 全文大小：522 K
• 卷排序：50

文摘

Periostin is a potential systemic biomarker for Type 2 asthma and other diseases. The Roche Elecsys® Periostin immunoassay measures periostin in human serum. The technical performance of the assay was evaluated and data presented. The fully automated assay will be useful in a routine clinical setting.